Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000580114 | SCV000683582 | uncertain significance | Hereditary cancer-predisposing syndrome | 2019-04-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001318010 | SCV001508697 | likely benign | Hereditary breast ovarian cancer syndrome | 2023-04-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000580114 | SCV002620143 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-05-19 | criteria provided, single submitter | clinical testing | The p.A127S variant (also known as c.379G>T), located in coding exon 3 of the BRCA2 gene, results from a G to T substitution at nucleotide position 379. The alanine at codon 127 is replaced by serine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
All of Us Research Program, |
RCV004803168 | SCV005424238 | uncertain significance | BRCA2-related cancer predisposition | 2024-09-23 | criteria provided, single submitter | clinical testing | |
Sharing Clinical Reports Project |
RCV000077313 | SCV000109110 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2012-05-03 | no assertion criteria provided | clinical testing | |
Breast Cancer Information Core |
RCV000077313 | SCV000146714 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 2 | 2002-06-20 | no assertion criteria provided | clinical testing |